Effects of dosing regimens and routes of administration on organophosphorus ester induced delayed neurotoxicity.
D000284:Administration, Oral; D000818:Animals; D001259:Ataxia / Q000139:chemically induced*; D002645:Chickens; D004305:Dose-Response Relationship, Drug; D007279:Injections, Subcutaneous; D007306:Insecticides / Q000633:toxicity*; D010773:Leptophos / Q000633:toxicity; D009943:Organophosphorus Compounds / Q000633:toxicity*; D063086:Organothiophosphates / Q000633:toxicity; D009946:Organothiophosphorus Compounds / Q000633:toxicity; D004849:Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester / Q000633:toxicity; D013329:Structure-Activity Relationship
D007306:Insecticides; D009943:Organophosphorus Compounds; D063086:Organothiophosphates; D009946:Organothiophosphorus Compounds; D004849:Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester; C006863:butyl phosphorotrithioate; D010773:Leptophos; C015342:merphos